Journal article

Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?

JA Holmes, PV Desmond, AJ Thompson

Journal of Viral Hepatitis | WILEY | Published : 2012

DOI: 10.1111/jvh.12003

Citation metrics

33Web of Science
31Scopus

Keywords

Cost-Effectiveness
Ns5b Polymerase
Virus-Infection
Interleukins
Polymorphism, Genetic
Genetic-Variation
Hepatitis C Virus
Association
Gastroenterology & Hepatology
Humans
Drug Therapy, Combination
Spontaneous Clearance
Hepatitis C, Chronic
Ribavirin Therapy
Ns3 Protease
Sustained Virological Response
Infectious Diseases
Prognosis
Genotype
Virology
Polymorphism
Antiviral Agents
Il28b Polymoprhism
Science & Technology
Ns5a Protein
Interleukin 28b
Treatment Outcome
Rapid Virological Response
Telaprevir
Life Sciences & Biomedicine